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Caveolin plays an essential role in the formation of
characteristic surface pits, caveolae, which cover
the surface of many animal cells. The fundamental
principles of caveola formation are only slowly
emerging. Here we show that caveolin expression
in a prokaryotic host lacking any intracellular mem-
brane system drives the formation of cytoplasmic
vesicles containing polymeric caveolin. Vesicle
formation is induced by expression of wild-type cav-
eolins, but not caveolin mutants defective in caveola
formation in mammalian systems. In addition, cryo-
electron tomography shows that the induced mem-
brane domains are equivalent in size and caveolin
density to native caveolae and reveals a possible
polyhedral arrangement of caveolin oligomers. The
caveolin-induced vesicles or heterologous caveolae
(h-caveolae) form by budding in from the cyto-
plasmic membrane, generating a membrane domain
with distinct lipid composition. Periplasmic solutes
are encapsulated in the budding h-caveola, and puri-
fied h-caveolae can be tailored to be targeted to
specific cells of interest.
INTRODUCTION
Membrane domain formation is a fundamental feature of eukary-
otic cells. One of the best characterized surface features is the
caveola, a bulb-shaped invagination of the plasma membrane
of animal cells (see Parton and Simons, 2007; Thomas and
Smart, 2008 for recent reviews). The requirement for the integral
membrane protein caveolin in caveola formation has been
substantiated by deletions in caveolin-1 (Drab et al., 2001;
Razani et al., 2001) and -3 (Galbiati et al., 2001; Hagiwara
et al., 2000) genes, as well as the introduction of caveolin752 Cell 150, 752–763, August 17, 2012 ª2012 Elsevier Inc.expression in a cellular context in which caveolin is normally
not present (Fra et al., 1995; Fujimoto et al., 2000; Vogel et al.,
1998). Three basic types of caveolin proteins have been recog-
nized: caveolin-1 and -3, giving rise to morphological caveolae
inmammalian cells, and caveolin-2 and relatedmolecules, which
do not give rise to caveolae in mammalian cells, as well as the
members of the extended CavY family that in some cases do
give rise to observable caveolae (Kirkham et al., 2008). Both N
and C termini of the caveolin polypeptide have been shown to
reside in the cytoplasm, whereas a highly hydrophobic segment
of approximately 33 amino acids is predicted to insert into
cellular membranes (Dupree et al., 1993). Caveolin proteins
have been shown to be synthesized as integral membrane
proteins at the endoplasmatic reticulum (Monier et al., 1995).
An intriguing aspect of caveolin biology is the fact that the poly-
peptide undergoes multiple changes on its exocytic route from
the site of synthesis to the plasma membrane (Hayer et al.,
2010). Oligomers of intermediate size have been reported shortly
after biosynthesis (Monier et al., 1995; Scheiffele et al., 1998). At
some as yet undefined stage along the exocytic route from the
Golgi complex to the plasma membrane, caveolin oligomers
finally associate with lipid components typically found in deter-
gent-resistant membranes and are henceforth organized in
discrete units of large-molecular weight oligomers, giving rise
to ‘‘exocytic caveolar carriers’’ (Parton and Simons, 2007).
Caveolin oligomerization and formation of membrane domains
enriched in cholesterol and glycosphingolipids are believed to
be critical for caveolae formation (Anderson, 1998; Hayer et al.,
2010; Parton et al., 2006). However, attempts to study the effects
of specific caveolin mutations on caveola formation are often
impaired by the problem of export from the ER/Golgi complexes
(Kirkham et al., 2008; Ren et al., 2004).
The exact mechanism of caveola formation, or caveogenesis,
remains largely enigmatic. To understand caveolin-membrane
interactions, a simplified model system for caveola formation,
in which lipid and protein composition can be modulated, would
represent amajor step forward. Here, we report the development
of a model for caveola formation. We show that membrane
Figure 1. Formation of Heterologous Cav-
eolae in E. coli
Cells were processed as described in methods.
(A) Time-course: t0, beginning of protein expres-
sion, labeling is associated with the inner
membrane (small arrowheads) and occasionally
with invaginations (see inset; large arrowhead).
Intracytoplasmic vesicles are clearly evident after
30 min to 90 min, until after 120 min the entire
cytoplasm, in many cells, is filled with vesicles.
Inset in 12 hr expression: anti-MBP immunoblot
showing protein levels at individual time points.
(B and C) High-pressure fast-frozen, freeze-
substituted, and Epon-embedded E. coli showing
an h-caveola undergoing fission from the cyto-
plasmic membrane (indicated by arrowhead).
(D and E) Cells expressing MBP-caveolin-1 with
entire cytoplasm filled (D), and higher magnifica-
tion of vesicular structures in the cytoplasm (E).
(F) Detail of high-pressure fast frozen, freeze
substituted E. coli expressing MBP-caveolin1
showing cytoplasmic vesicles.
Scale bars: (A and D) 200 nm, (A, inset, E, and F)
100 nm, (B and C) 20 nm. See also Figure S1 and
Movie S1.vesicles, produced by scission of the caveolar domain from the
membrane, can be induced by recombinant caveolin expression
in the heterologous host Escherichia coli. This system provides
fundamental insights into membrane domain formation, defor-
mation of a biological membrane driven by caveolin, and the
organization of a caveolar coat in an extremely tractable model
system. In addition, we show that solutes can be incorporated
into the caveolin-induced vesicles and that the vesicles can be




In order to investigate the interaction of caveolin proteins with
biological membranes, we heterologously expressed a wide
spectrum of caveolin proteins in the prokaryotic host E. coli.
Whereas the vast majority of the recombinant protein was asso-
ciated with the host membrane (and inclusion bodies wereCell 150, 752–763absent), large quantities of recombinant
protein could be affinity purified without
detergent solubilization. Therefore, the
localization and nature of the recombi-
nant caveolin proteins was investigated
by immunoelectron microscopy. In cells
expressing caveolin-1, a striking accumu-
lation of circular profiles, 45–50 nm in
diameter, was observed within the cyto-
plasm (Figure 1 and Figure S1). Upon
expression of the caveolin construct, the
cytoplasm of the host cells would in
many cases become utterly filled with
these internalized structures as exempli-fied in a tomographic reconstruction of part of the host cell
(Movie S1). To investigate the process by which these structures
are produced, we examined the localization of recombinant
caveolin-1 at early times of protein expression. Specific labeling
with antibodies against the recombinant protein was seen
predominantly at the inner membrane of the host cells (Figures
1A, 1D, and 1E). At this time point, sparse labeling was detected
within the center of the bacteria, but over time labeled vesicles
accumulated throughout the entire cytoplasm of the bacteria
(Figures 1A and 1D and Figure S1). Equivalent structures were
observed for various caveolin proteins tested, i.e., mammalian
caveolin-1 and -3 and also teleostean caveolin-1 (data not
shown). Vesicular structures were not induced by chemical fixa-
tives, as shown by high-pressure cryopreservation followed by
freeze-substitution (Figures 1B, 1C, and 1F). These results
suggest that the vesicles are derived from the inner membrane
by an inward budding process. Consistent with this notion,
profiles were observed that were connected to the membrane
(Figures 1A–1C). These structures showed striking similarity to, August 17, 2012 ª2012 Elsevier Inc. 753
Figure 2. Characterization of Purified
h-Caveolae
(A) Uranyl acetate staining of purified vesicles.
(B) Upper: MBP-TEV-caveolin1-His6 could be
affinity purified by using either the N-terminal MBP
affinity tag (lanes 1 and 2) or the C-terminal
hexa-histidine (lane 3). SDS-PAGE stained with
Coomassie brilliant blue. Lane 1, full-length MBP-
caveolin1-His6; lane 2, TEV protease cleavage of
fusion protein; lane M, protein molecular weight
marker; lane 3, full length MBP-TEV-caveolin1-
His6 purified on Ni-NTA. Lower: anti-caveolin-1
(BD Transduction Laboratories) immunoblot of
purified h-caveolae. h-caveolae were expressed
as C-terminal hexa-histidine fusion with caveolin-1
and purified on Ni-NTA. Lane 1, lysate; lane 2,
flow-through; lane 3, purified h-caveloae.
(C) Coomassie-stained SDS-PAGE of affinity
purified heterologous caveolae: () full-length
MBP-caveolin, (+) TEV protease cleavage.
(D) Cryo-EM of vitrified h-caveolae.
(E) Dynamic light scattering of purified h-caveolae.
(F–H) Immunogold-labeling of h-caveolae: MBP-
Cav1-His6 h-caveolae were blocked in 1% bovine
serum albumin and 1% fish skin gelatin and
labeled with (F) a-MBP antibody (New England
Biolabs), (G) a-Caveolin-1 (Transduction Labs),
and (H) and VIP-N antibody. The h-caveolae were
then incubated with 5 nm Protein-A gold and
stained with 0.4% uranyl acetate in 2% methyl
cellulose.
Scale bars, (A) 200 nm, (D, F, G, and H) 100 nm.the morphology of surface caveolae in mammalian cells, both as
surface invaginations and as budded caveolae. In view of the
induction of these structures by caveolin, the apparent formation
at the membrane and their morphology, we termed these struc-
tures ‘‘heterologous caveolae’’ or ‘‘h-caveolae.’’
Characterization of Heterologous Caveolae
Analysis of purified h-caveolae by negative-staining electron
microscopy showed the presence of numerous 45–50 nm vesi-
cles (diameter of membrane) with a prominent coat (Figure 2A),
consistent with the observed induction of h-caveolae in the
cytoplasm described above. h-caveolae could be produced
and purified by engineering an affinity tag at either C or N
terminus, suggesting that the topology of the protein was as
predicted (Dupree et al., 1993) (Figure 2B). Single-step affinity
chromatography of h-caveolae yielded an essentially pure prep-
aration of maltose-binding protein (MBP)-caveolin-1 as judged
by Coomassie blue staining of SDS-PAGE separated proteins
(Figure 2C). Remarkably, endogenous (membrane) proteins
were below the limits of detection. Affinity purified h-caveolae
showed a monodisperse distribution with a median hydrody-
namic radius around 59 nm (Figure 2E). Immunogold labeling
with antibodies to MBP or to different caveolin epitopes
confirmed the presence of the caveolin fusion protein on the
surface of these purified structures (Figure 2F–2H). To gain
further insights into the ultrastructure in essentially a native state,
purified h-caveolae were rapidly frozen and examined in a vitri-
fied state without fixatives or stains (Figures 2D and 5A). The cry-754 Cell 150, 752–763, August 17, 2012 ª2012 Elsevier Inc.ofixed h-caveolae showed a well-defined coat, consisting of
regularly spaced protrusions from themembrane, approximately
4 3 2 nm in dimension (vide infra).
We next investigated whether caveolin isoforms and mutant
proteins that do not generate caveolae in mammalian cells,
i.e., noncaveogenic isoforms, could bring about the formation
of h-caveolae in this model system. In this prokaryotic model
system, neither caveolin-2 nor Caenorhabditis elegans caveolin
gave rise to h-caveolae, as defined above by their size and
geometry. When expressed in E. coli, both caveolins associated
with the cytoplasmic membrane and apparently resulted in an
expansion of membranous material, giving rise to pleiomorphic
membranous inclusions (Figures 3A–3E). A tomographic recon-
struction of part of a caveolin-2 expressing cell exemplifies the
variable nature of these inclusions in comparison to the h-caveo-
lae formed by mammalian caveolin-1 (Movie S2). Extending the
validation of the current model system for caveolar biogenesis,
we sought to establish whether mutations mimicking phosphor-
ylation of caveolin-1 at the conserved Ser80 would influence its
ability to form h-caveolae. Expression of mutant caveolin-1 in
which Ser80 is substituted by glutamate in caveolin null cells
results in accumulation of the mutant caveolin in the Golgi
complex and no caveola formation, whereas an alanine substitu-
tion permits caveola formation in the same system. It has been
hypothesized that Ser80 may play a key role in regulating the
association of a postulated amphipathic helix (helix a2a, resi-
dues 80-95) with the membrane interface (Kirkham et al., 2008;
Parton et al., 2006). Our data suggest that the S80E mutation
Figure 3. Expression of ‘‘Noncaveogenic’’ and Mutant Caveolin
Proteins
Recombinant C. elegans caveolin-MBP fusion protein, MBP-caveolin-2 or
MBP-caveolin-1Ser80Glu were expressed.
(A and B) C. elegans caveolin induces the formation of very large and irregular
membrane inclusions in the cytoplasm (indicated by arrows). (A) chemically-
fixed, cryosectioned cells. (B) high-pressure fast-frozen cells. The insets
highlight areas of prolific accumulation of internal membranous material.
(C–E) Mammalian caveolin-2 induces the formation of thin tubules (indicated
by arrows) with few vesicular structures evident. (D) Arrows indicate stacked
membranes, (E) arrows indicate longitudinal tubular profiles; chemically-fixed.
(F) caveolin-1S80E induces formation of irregular structures and tubular profiles
(inset) as indicated by arrows; chemically-fixed.
Scale bars, 200 nm. See also Movie S2.is indeed noncaveogenic in this model system, while again giving
rise to pleiomorphic membranous inclusions (Figure 3F). In
contrast, S80A substitution gave rise to h-caveolae equivalent
to thewild-type protein in geometry (data not shown). The forma-
tion of oligomeric assemblies has been shown to constitute an
integral part of the biology of caveolae (Das et al., 1999; Monier
et al., 1995; Sargiacomo et al., 1995). We therefore tested
whether mutant caveolin proteins, partially or completely
impaired in their ability to oligomerize in mammalian cells (Ren
et al., 2004), would fail to do so in this heterologous model. All
mutants exhibited a marked reduction in protein stability in vivo
(Figure S2B), in stark contrast to the stability of the wild-type
protein expressed in the same system. Expression in a host
strain (ftsH) depleted for the membrane protease FtsH (a keycomponent of the host’s quality control system for integral
membrane proteins [Ito and Akiyama, 2005]) ameliorated the
apparent lack of stability of the mutant proteins. Wild-type
caveolin was found to behave exclusively as a high-molecular-
weight complex on sucrose gradients when solubilized with
Triton X-100. The missense mutation P132L, a naturally occur-
ring mutation with relatively high frequency in human mammary
carcinoma (Hayashi et al., 2001), showed a skewed distribution
of monomeric and oligomeric species on gradients. Two other
mutant proteins (118A5 and G108/A112/S123/H126 all to L),
showed predominantly monomeric or low-molecular-weight
oligomeric distribution (Figure S2A).
Structural Analysis of Heterologous Caveolae
Around 144 ± 39 molecules of caveolin have been estimated to
associate with a single caveola in mammalian cells (Pelkmans
and Zerial, 2005). In order to establish the validity of the current
system as a model for caveogenesis, we have undertaken struc-
tural characterization of the h-caveola by cryoelectron tomog-
raphy. Reconstruction of the electron density by weighted
back-projection of the tomographic tilt series revealed a discrete
organization of the caveolar coat on purified h-caveolae (Figure 4
and Movie S3). The electron density apparent in the reconstruc-
tion is for the most part the density of the fusion protein as is
demonstrated by the proteolytic cleavage and removal of the
MBPmoiety prior to cryoelectronmicroscopy (Figure S3). Never-
theless, this has enabled us to quantify the number of fusion
proteins in the coat and visualize the arrangement of individual
caveolin oligomers on the surface of the h-caveola. The average
number of nonoverlapping density peaks after cleavage was
10.3 ± 1.2 (Figure S3, n = 13). When combined with a cleavage
efficiency of 93.7%—as determined by immunoblotting—
this indicates an average of 163.9 ± 19.5 fusion proteins per
h-caveola, which is remarkably similar to the number of caveo-
lins molecules predicted to associate with a single caveola in
mammalian cells (Pelkmans and Zerial, 2005).
Even at the low resolution of the cryotomograms, a discrete
arrangement of caveolin oligomers was evident (Figure 4 and
Movie S3). Volumetric reconstructions (n = 8) suggested a
polyhedral organization of putative caveolin oligomers (as sug-
gested in Figure 4). For the reconstructed densities, an icosahe-
dral symmetry with 2-fold symmetries along x, y, and z axes was
detected with a map correlation of 0.991 ± 0.007 (SD, n = 8). In
agreement with this model, we found that vitrified h-caveolae
often presented polygonal profiles of decagonal appearance,
exhibiting parallel lines and constant angles between edges
(Figure 5A). Such a projection from a putative polyhedron was
also evident in the slices of the tomographic reconstruction
(Figures 4A–4C). The observation of distinct geometric ‘‘faces’’
suggested that the arrangement may indeed be polyhedral. To
corroborate a potential polyhedral model, we analyzed the pres-
ence and geometry of discrete building blocks of oligomeric
caveolin by detergent treatment and subsequent transmission
electron microscopy (TEM). Based on our previous results in
solubilizing oligomeric caveolin from the heterologous host (Fig-
ure S2), we hypothesized that treating purified h-caveolae with
Triton X-100 would result in release of oligomeric caveolin from
the vesicular structure and would facilitate visualization ofCell 150, 752–763, August 17, 2012 ª2012 Elsevier Inc. 755
Figure 4. Cryoelectron Tomographic
Reconstruction and Modeling of Heterolo-
gous Caveolae
(A–C) sections through a purified MBP-caveolin-1
h-caveola. (A) polar/top section, (B) equatorial
section, and (C) polar/bottom section.
(D–I) volumetric density rendering of the tomo-
graphic reconstruction of two representative
h-cavolae: (D/G) polar/top, (E/H) equatorial, (F/I)
polar/bottom. Red mesh represents density
contoured at 1.75, solid blue at 2, and solid yellow
at 2.5 SD above mean density value for the
map. Clipping planes also represent these
contouring levels.
Scale bars, 250 A˚. See also Figure S3 and
Movie S3.caveolin organization. Indeed, discretely organized caveolin
became evident upon aldehyde fixation and detergent extrac-
tion, in stark contrast to the density in the uncrosslinked
h-caveolae, which did not retain any organization (of caveolin
oligomers) and was reduced to a randomly oriented mass
(data not shown). Intriguingly, distinct regular pentagons were
discernable in the chemically fixed and detergent extracted
h-caveolae (Figures 5B and 5C). Moreover, a 3-fold symmetrical
arrangement of pentagonal substructures could be identified
(Figure 5B), resembling the 3-fold relation observed for purified
400 kDa caveolin polymers from mammalian cells (Monier
et al., 1995). This provides the first evidence that the organization
of caveolin oligomers, leading to the formation of h-caveolae,
could be achieved by formation of a regular polyhedron.
Induced Membrane Domain Formation
We next hypothesized that the dramatic membrane changes
induced by caveolin expression must be reflected by changes
in lipid composition of the host inner membrane and that the
h-caveola may sequester (and require) specific lipids during
formation. We therefore compared the lipid profiles of purified
h-caveolae with total extractable lipids from cells prior to protein
expression and cells expressing caveolin (as MBP-caveolin-1) at
steady-state levels. Using mass spectrometric analysis, we
identified 84 lipids belonging to seven lipid classes, namely756 Cell 150, 752–763, August 17, 2012 ª2012 Elsevier Inc.lysophosphatidylethanolamine (LPE), ly-
sophosphatidylglycerol (LPG), phospha-
tidic acid (PA), phosphatidylethanolamine
(PE), phosphatidylglycerol (PG), cardioli-
pin (CL, di-phosphatidylglycerol) and
diacylglycerols (DAG). A summary of lipid
identification is presented in Table S1.
The comparison of lipid profiles revealed
that the formation of h-caveolae lead to
a complex alteration of glycerophospholi-
pid composition in terms of abundance
of lipid classes and fatty acid (FA) distri-
bution. An unbiased cluster analysis
grouped all independently determined
lipid profiles of the host lipids prior to
expression of caveolin with a correlationfactor of 0.95 and with a correlation factor of 0.87 for the
h-caveolae lipid profiles (Figure 6A). The expression of caveo-
lin-1 led to a decrease in abundance for short acyl backbones
such as 30:1; 30:0; 32:2; and 32:1 and was accompanied by
an increase of LPE and LPG/PG at the expense of PE (Figures
6A and 6B). Analysis of the identified lipid species revealed
that relative FA composition of both major membrane lipids PE
and PG showed a marked decrease for FA 16:1 and FA 14:0
and a concomitant increase in long-chain FAs and unsaturated
FA (either in form of unsaturated or previously unsaturated but
later cyclopropanated FA as is typical for the heterologous
host upon entry into stationary phase of the culture (Cronan,
2002). As shown above, the noncaveogenic caveolins (e.g.,
caveolin-2 and CeCav-a) gave rise to structures significantly
diverging from the prototypical caveola, in contrast to the heter-
ologous caveolin-1 (cf. Figures 3A–3E and Figure S4). We there-
fore analyzed whether this was accompanied by distinct
changes to the lipidome of these membranes and in particular
for the purified structures relative to caveolin-1 (Figure S4).
Encapsulation of Solutes within h-Caveola and
Targeting of Particles
Immunoelectron microscopic analyses suggested a sequence
of events involving incorporation of caveolin polypeptide into
the inner membrane of the host, membrane deformation,
Figure 5. Cage Structures and Organiza-
tional Units of h-Caveolae
(A) Cryo-EM of vitrified h-caveolae. Upper:
individual h-caveolae; lower: shows the same
h-caveola with a regular decagon inscribed as
indicatedby thedashedwhite line.Scale bar, 25nm.
(B) Fixation and detergent extraction of fixed
h-caveolae. Purified h-caveolae were chemically
fixed, extracted, and negatively stained with UOAc
asdescribed inExtendedExperimentalProcedures.
Left: a partially disrupted h-caveola. Right: linear
building blocks observed as white dashed lines.
Scale bar 100 nm.
(C) Examples of polygonal repeating units in the
h-caveolae cage after fixation and detergent
extraction. To better preserve the cage, a milder
detergent extraction method was employed as
described in Extended Experimental Procedures.
Arrows indicate areas of conservation of ring
structures. Scale bars: 50 nm.
(D) Tomographic reconstruction of the cage in fixed
and extracted h-caveolae. Scale bars: (left) 50 nm,
(right) 5 nm.invagination, and, finally, fission from the cytoplasmicmembrane
(see also Figures 1B and 1C). To test this hypothesis, we incu-
bated cultures with membrane impermeant fluorescent dyes
that can penetrate the more permeable outer bacterial
membrane via hydrophilic pores (and so enter the periplasmic
space) but cannot cross the cytoplasmic membrane. Dyes
were added to the growing cultures prior to protein expression
to allow for diffusion of the small molecules. Consistent with the
above hypothesis for formation of h-caveolae, cells expressing
caveolin-1 showed significant fluorescencewhen smallmolecule
dyes were present at the time of formation (Figures 7A–7C). InCell 150, 752–763many cases the fluorescence was
concentrated in distinct areas of the cells
(predominantly polar regions) in accor-
dance with the accumulation of h-caveo-
lae in these regions evident in electron
micrographs (Figures 1A). In complete
contrast, control cells (only expressing
MBP) showed no fluorescence under the
same conditions (Figure 7C). We were
able to purify h-caveolae containing
various smallmolecules anddyes, consis-
tent with the encapsulation and indeed
nonleaky entrapment of periplasmic
solutes into the emerging structures
(Figures 7D–7F and Figure S5). In addition
to the incorporation of small molecule
dyes, it was possible to incorporate
protein—albeit with lower efficiency—
into h-caveolae. The addition of horse-
radish peroxidase to the culture medium,
combined with transient disruption of
the outer membrane, enabled us to
subsequently detect its incorporation
by reaction with 3,3’-diaminobenzidine(DAB) (see Extended Experimental Procedures for alterations to
the standard protocol) (Figures 7G and 7H). Extending the appli-
cation of modified h-caveolae, we testedwhether purified h-cav-
eolae containing targeting information could be specifically
directed to target cells. We adapted the caveolin polypeptide
with both GFP and a synthetic immunoglobulin-binding domain
(Z domain derived from Staphylococcus aureus protein A).
When these h-caveolae[GFP-Z] were incubated with SK-BR-3
breast cancer cells—overexpressing endogenous erb-B2 recep-
tors—no observable binding or internalization into the cells was
detected (Figure 7J). However, if the h-caveolae[GFP-Z] were, August 17, 2012 ª2012 Elsevier Inc. 757
Figure 6. Lipidomic Analysis
Shotgun lipidomic analysis of the host lipidome and membranes of purified h-caveolae was carried out in response to caveolin expression (preinduction,
postinduction) as described in Experimental Procedures.
(A) Heat map of hierarchical clustered lipid profiles consisting of 68 lipids of host strain before expression of caveolin and isolated h-caveolae (the color scale
depicts the log2 transformed alterations in lipid abundances). Clustering correlation coefficients for the clades are indicated for the basal branch in the cladogram.
(B) Relative abundance of phosphatidylethanolamine (PE), phosphatidylglycerol (PG), phosphatidic acid (PA), cardiolipin (CL), lysophosphatidylethanolamine
(LPE), and lysophosphatidylglycerol (LPG) expressed as the sum of normalized intensities of all lipids.
(C) Profiles of individual PE species with relative abundance above 0.5%.
(D) FA composition of major lipid classes PE and PG. Bars represent the mean of the minimum of three biological replicates with two technical repetitions ± SD.
See also Figure S4 and Table S1.
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adapted with the monoclonal antibody Trastuzumab (specific
for erb-B2), a specific binding, internalization and progression
into multivesicular bodies was observed (Figures 7I–7N and
Figure S6). Specificity of this targeting and internalization was
corroborated by coculturing SK-BR-3 cells (erb-B2+) with MCF-
7 cells (lacking the same level of growth factor receptor). Trastu-
zumab conjugated h-caveolae[Z] were seen to internalize into
erb-B2 positive SK-BR-3 cells but not MCF-7 cells (Figure 7N).
DISCUSSION
Implications for Caveolar Biogenesis
The model system described here provides fundamental new
insights into the process by which a morphologically distinct
microdomain is induced by caveolins. Our findings show for
the first time that the caveolin polypeptide is sufficient for gener-
ation of membrane curvature and scission in a simple membrane
system. A number of findings emphasize the relevance of this
model system to caveola formation in native cells: first, caveo-
lin-induced h-caveolae are strikingly similar in morphology to
caveolae in mammalian cells; second, the number of caveolin
molecules in a h-caveola is similar to the density of caveolin in
native caveolae in vivo; and third, caveolin mutants and iso-
forms, including single-point mutants, which do not generate
caveolae in mammalian cell systems, do not induce h-caveola
formation in this heterologous system. We here provide a model
of how caveolin oligomers may arrange to create the proteina-
ceous coat on caveolae. A polyhedral arrangement, as inferred
from our data, may explain the presence of discrete quantities
of caveolin observed in native caveolae (Pelkmans and Zerial,
2005) and lays the foundation for a systematic structural elucida-
tion of caveolin coat assembly (vide infra). There are, however,
also significant differences to eukaryotic systems: caveolae in
mammalian cells require cholesterol for stability, and cholesterol
depletion, in turn, flattens caveolae (Rothberg et al., 1992). Cav-
eolae budding in mammalian cells is a highly regulated process
(Pelkmans and Zerial, 2005). In addition, recent work has shown
that cytoplasmic coat proteins cooperate with caveolin to form
stable caveolae (Hill et al., 2008). In contrast to the situation in
mammalian cells, which have evolved to allow precise spatio-
temporal regulation of caveola formation, we postulate that the
E. coli membrane composition permits stable cholesterol-inde-
pendent association of the postulated caveolin amphipathic
helices with the membrane. The formation of the caveolar
membrane domain appears to result in sequestration of distinct
lipid species. It may thus be fortuitous that the membrane
composition of the host allows for such deformation to take
place. Nevertheless, in this biological membrane the caveolin
protein is sufficient for the induction of membrane curvature
and ultimately cincture of a coated vesicle. It appears reasonable
to postulate that although lipid composition will obviously be
different in animal cells, fundamental principles governing how
the caveolin polypeptide deforms a biological membrane remain
analogous as corresponding lipid-protein interactions would
have to take place to allow the formation of a membrane domain
equivalent in size and in number of coatingmolecules. Themark-
edly increased relative abundance of lyso-phospholipids in
particular may suggest how strong positive membrane curvaturecould be achieved on the outer leaflet of the membrane at the
annular ring of a caveolar invagination (before cincture of the
caveola) where no caveolin protein oligomers would be present.
This may be the role of glycosphingolipids in native/mammalian
caveolae because these would be located exclusively on the
outer leaflet of the plasma membrane. Peptides encompassing
the postulated amphipathic helix of caveolin have been reported
to induce the formation of lipid domains enriched in (mammalian
type) acidic phospholipids upon mixing with vesicles (Wanaski
et al., 2003). The data reported here support the above hypoth-
esis: first, the increased abundance of acidic lipids (phosphati-
dylglycerol and lyso-phosphatidylglycerol) in the caveolar
membrane domain suggests specific interaction with these
phospholipid species; second, distinct acyl composition was
observed representing an increased proportion of long-chain
(unsaturated) FAs; third, disruption of the postulated interaction
through introduction of a negative charge in the Ser80Glumutant
essentially renders the protein ‘‘noncaveogenic’’ as defined by
geometry. The budding of caveolin-containing microdomains
to produce vesicles raises the possibility that caveolin oligomer-
ization and lipid interactions are sufficient to cause caveolin
invaginations to cincture from the parental membrane and vesic-
ulate it in a ‘‘permissive’’ lipid environment. In contrast, the lipid
composition of mammalian cells may not represent such
a permissivemembrane environment and thus various additional
proteins regulate andmodulate caveogenesis in native cells. The
prokaryotic system therefore identifies the fundamental proper-
ties of the caveolin protein but the data from mammalian
systems indicate that additional levels of regulation must exist
in higher eukaryotes, conveyed by peripheral caveolar proteins
such as cavins (Bastiani and Parton, 2010) and/or F-BAR-
domain-containing proteins such as pacsin2 (Senju et al.,
2011; Hansen et al., 2011).
Structure Elucidation of Vesicular Coats
Proteinaceous coats covering the surface of eukaryotic endo-
membrane systems are well documented and structural models
for their organization have recently begun to emerge (Stagg
et al., 2007; Lee and Goldberg, 2010). To date, the caveolar
membrane system has eluded a mechanistic understanding
and indeed any structural characterization. We here employed
a fusion protein, which is relatively large compared to the caveo-
lin polypeptide (178 amino acids of which a large fraction is
embedded in or associated with the membrane) and structurally
well ordered, to pinpoint individual caveolin molecules in cryo-
EM studies. The use of a large reporter protein for electron
microscopy does, however, come at a price: the potential
centers of symmetry inferred by the current model are imposed
by the assembly of the small integral membrane protein caveolin,
not by the MBP domain (which is monomeric, even in the dense
packing of a protein crystal [Quiocho et al., 1997]). Nevertheless,
this method allowed us to visualize a potential polyhedral
arrangement of caveolin, for the first time providing a new exper-
imentally tractable model for caveola formation.
An interesting comparison can be made to in vitro studies
of clathrin-coated vesicle (CCV) formation: in a model system,
epsin (amphipathic helix insertion) and clathrin (oligomerization
to form a cage) are sufficient to cause vesicle formation (FordCell 150, 752–763, August 17, 2012 ª2012 Elsevier Inc. 759
Figure 7. Encapsulation of Small Molecules in h-Caveolae and Targeted Delivery
E. coli transformed with MBP-caveolin-1 were incubated in presence of fluorescent dyes as described in methods.
(A) 5-(dimethylamino)naphthalene-1-sulfonate (DANS).
(B) 5-(6-)carboxyfluorescein, inset shows inherent fluorescence of GFP-fused h-caveolae for comparison.
(C) MBP-only expressing control cells incubated with 5-(6-)carboxyfluorescein. Inset: anti-MBP immunoblot of cultures (1: MBP-caveolin1; 2: MBP).
Scale bars, 10 mm.
(D and E) Quantification of specifically encapsulated fluorescence uponMBP-caveolin orMBP-only expression, respectively: (D) 5-(6-)carboxyfluorescein and (E)
tetrabromofluorescein. Bars represent average of four repetitions ± SD (n = 4, *p < 0.05).
(F) Fluorescent appearance of cells incorporating 5-(6-)carboxyfluorescein before (left) and after washing (right) 1: MBP-caveolin1; 2: MBP.
(G and H) Incorporation of protein cargo into h-caveolae: exogenous horseradish peroxidase was included in the culture medium and detected based on
peroxidase activity as described in Extended Experimental Procedures. Scale bars, 500 nm.
(I–L) Internalization of targeted fluorescent h-caveolae in SK-BR-3 cells. (I) Binding and internalization h-caveolae[GFP-Z] + Trastuzumab. (J) h-caveolae[GFP-Z]
without Trastuzumab. (K) h-caveolae[GFP-Z] + Trastuzumab, internalized then acid washed. (L) h-caveolae[GFP-Z] + Trastuzumab, acid washed prior to
internalization. Scale bars, 10 mm.
(M) Optical slice through a tomographic reconstruction of h-caveolae[GFP-Z]. Scale bar, 50 nm.
(N) Specific uptake of targeted, Trastuzumab conjugated h-caveolae[Z] into erb-B2 positive cells. SK-BR-3 cells were cocultured withMCF-7 cells and the uptake
of h-caveolae[Z] followed by anti-caveolin antibody labeling. Scale bar, 10 mm.
See also Figures S5 and S6.
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et al., 2002). Strikingly, Boucrot and coworkers have shown that
shallow hydrophobic insertions by amphipathic helices (epsin
ENTH domain) are sufficient for vesiculation of liposomes and
that epsin can indeed support CCV budding in cells where dyna-
min is depleted by means of siRNA (Boucrot et al., 2012).
Furthermore, this ability was shown to be sensitive to the integ-
rity of its amphipathic helix, as shown by themutation of a leucine
to an acidic residue on the hydrophobic face of the helix (Boucrot
et al., 2012). An analogy can be drawn to the proposed interac-
tions of caveolin suggested here and in previous studies (Kirk-
ham et al., 2008; Parton et al., 2006): the mutation Ser80Glu (in
the postulated amphipathic helix a2a of caveolin) was shown
to impair formation of h-caveloae.
Recently, the elucidation of the COPI ab’-COP subcomplex
structure demonstrated that the core of the proposed COPI
coatamer organizes as a triskelion, imposing a three-way vertex
onto the cage (Lee and Goldberg, 2010). Although there are
significant differences in the assembly of eukaryotic vesicular
coats, it appears that these coat proteins share common mech-
anisms in assembly with regard to protein folds employed in the
process (e.g., triskelion assembly for clathrin and COPI with
a-solenoid extensions of the legs and vertex assembly employ-
ing the N terminal b-propeller domains for COPI and COPII).
One intriguing difference to all other vesicular cages is that the
assembly of the caveolar cage postulated here is accomplished
by a single protein. In addition, the organizing unit for the
assembly of the coat is an integral membrane protein, whereas
assembly of COPII or clathrin coats is achieved by the
self-assembly and sequential incorporation of preforming cyto-
solic complexes onto membrane-bound adaptor protein com-
plexes (Cheng et al., 2007; Ehrlich et al., 2004; Fath et al.,
2007; Fotin et al., 2006) and reviewed in (Brett and Traub, 2006;
Gu¨rkan et al., 2006; Russell and Stagg, 2010). This raises the
possibility that size of the emerging structure is regulated in
a different manner and is likely a function of caveolin concentra-
tion in the membrane. A tentative model would imply growth of
linear head-to-tail caveolin oligomers (dimerization) of about
four to six units, giving rise to the pentagonal edges suggested
in Figures 4 and 5 (80 A˚ in length). Small oligomers would poly-
merize by trimerization representing the vertices of the assem-
bling putative polyhedral cage in a concentration-dependent
manner: smaller polyhedra would assemble when high concen-
trations are present, limiting the length of linear caveolin oligo-
mers (e.g., 4-mer and 5-mer linear units, giving rise to h-caveolae
with 120 and 150 subunits, respectively) and larger ones when
lower concentrations prevail (e.g., 6-mer linear units, giving rise
to h-caveolae with 180 subunits of caveolin). A two-step
assembly process (linear extension and subsequent trimerization
of preassembled linear oligomers) could be achievedby thepres-
ence of distinct oligomerization signals previously reported for
both the cytoplasmic part (Fernandez et al., 2002; Sargiacomo
et al., 1995; Schlegel and Lisanti, 2000; Song et al., 1997) and
within the integral membrane segment (Ren et al., 2004). Such
a model for caveogenesis may explain the presence of smaller
and larger h-caveolae seen in native caveolae (Pelkmans and Ze-
rial, 2005) and also occasionally seen in the heterologous model
system (a single, large h-caveola with1.5 times the diameter of
a regular h-caveola can be seen in Figure 1A, 900). Furthermore,the presence of discrete oligmeric caveolin species in detergent
solubilizedmembranes fromcanine cells (Monier et al., 1995) can
be explained by this model as individual segments of the cage,
which an earlier model of filamentous assembly (Fernandez
et al., 2002) does not readily account for. At the plasma
membrane of a native cell, the size of the assembling caveolin
oligomers and their stability will be regulated further by the action
of caveolar coat proteins, cavins, which have been shown to
modulate the formation and maintenance of caveolae (Hill
et al., 2008). This is unlikely to simply involve protein-protein
interactions but more likely involves cavin interactions with cav-
eolin-induced domains enriched in cholesterol and phosphatdyl-
serine (see Bastiani and Parton, 2010) and possibly curvature
sensing/partitioning by protein domains such as suggested for
pacsin2 (Hansen et al., 2011). Coexpression of such ancillary
proteins in this simple model system together with modulation
of lipid composition will now allow a molecular dissection of the
influence these modulating proteins wield on the assembly and
maintenance polymeric caveolin from ‘‘first principle.’’
Clathrin-coated vesicles isolated from natural sources, show
a marked degree of heterogeneity and also different possible
assembly types (Cheng et al., 2007). The biogenesis of
h-caveolae in the prokaryotic biological membrane is simpler
as it involves only a single polypeptide entity giving rise to a
cage. This presents a unique opportunity to modulate cage
size of the h-caveola by engineering the caveolin polypeptide
as discussed below.Implications for Biotechnology
The findings presented here provide the first characterization
of a potential drug-delivery vehicle that would represent a low-
cost, submicron drug encapsulation method that can be engi-
neered toward specific cellular targets. A very important aspect
of the h-caveola is that it represents a ‘‘genetically encoded
vesicle.’’ This unique vesicle is thus entirely defined and acces-
sible to manipulation through the caveolin polypeptide. The
coat of h-caveolae can be modified to a remarkable extent by
using translational fusions with the caveolin polypeptide. As we
have shown in this initial characterization, molecules (small
molecules and, importantly, even proteins) in the periplasmic
space can be encapsulated in the lumen of the h-caveola. Bio-
logically relevant small proteins (e.g., toxins, proteases) may
therefore be introduced into the lumen of h-caveolae in this
way and purified efficiently with the engineered particle. The
ability to add different targeting information to the caveolin mole-
cule (as exemplified here by antibody conjugated h-caveolae
specifically binding and internalizing into erb-B2 positive cells)
through simple recombinant technology in order to generate
uniformly sized drug carriers offers intriguing potential for a non-
synthetic nano-sized drug targeting system. In addition, these
carriers would profit from the fact that the protein structurally
responsible for the assembly is already a (fully) human protein.EXPERIMENTAL PROCEDURES
Expression of Caveolin and Purification of h-Caveolae
E. coli BL21 (lDE3) were grown in Terrific Broth and induced to express
recombinant proteins in late log phase under T7 RNA polymerase promoter.Cell 150, 752–763, August 17, 2012 ª2012 Elsevier Inc. 761
Protein expression was then allowed to progress over night at 25C, unless
stated otherwise. h-caveolaewere isolated by lysozyme treatment and sonica-
tion and purified by affinity chromatography on maltosyl-sepharose prepared
by divinyl sulfone coupling (Fornstedt and Porath, 1975) or commercial
amylase resin (NEB). h-caveolae were eluted with maltose in phosphate
buffered saline and concentrated using Vivaspin ultrafiltration units (Sartorius).
Encapsulation of Fluorescent Molecules
Host cells were grown by the standard procedure for expression of h-caveolae
as described above. Fluorescent molecules were added directly to the growth
medium at least two cell divisions prior to induction of h-caveola formation as
described in Extended Experimental Procedures.
Lipid Analysis
For the analysis of E. coli cultures containing MBP-caveolin-1, the equivalent
of 20 ml of a culture at an optical density (OD600nm) of one from three indepen-
dent cultures were collected by centrifugation. The cell pellets were washed
three times with 0.15 M NaCl, snap frozen in liquid nitrogen, and lyophilised.
Caveosphere preparations were isolated as described above and the protein
concentration determined by absorbance spectroscopy. For the lipid extrac-
tion from h-caveolae, three independent h-caveolae preparations equivalent
to 0.4 mg protein were collected. Following ultracentrifugation, pelleted h-cav-
eolae were resuspended in 50 ml H2O and lyophilized.
Prior to lipid extraction, the lyophilized cell mass was resuspended in 40 ml
150 mM ammonium acetate and h-caveolae preparations in 20 ml, respec-
tively. Lipid extraction was performed with a methyl tert-butyl ether based
extraction as described previously (Matyash et al., 2008). Mass spectrometric
analysis was performed as described in the Extended Experimental
Procedures.
Electron Microscopy
E. coli BL21 (lDE3) expressing recombinant MBP-caveolin1-His6 fusion
protein or MBP alone were processed for frozen sectioning and immunolabel-
ing with anti-MBP primary antibody (New England Biolabs), followed by 10 nm
protein A-gold or 15 nm colloidal gold secondary antibodies as described in
Extended Experimental Procedures. Cryo-EM tomography and reconstruction
is described in the Extended Experimental Procedures.
Targetting Assay
Human breast adenocarcinoma SK-BR-3 cells were seeded at 2.53 104 cells
per well in a 96-well plate in Dulbecco’s Modified Eagle Medium (GIBCO,
Australia) supplementedwith 20% (v/v) fetal calf serum and 2mML-glutamate.
Statistical Analysis
Statistical analysis was performed using Mann-Whitney U test and p values
below 0.05 considered significant as indicated in the figures and figure
legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, one table, and three movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2012.06.042.
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